Wiki Philippines

Tag: Philippines

  • Bases Conversion and Development Authority (BCDA)

    Definition

    The Bases Conversion and Development Authority (BCDA) is a Philippine government-owned and controlled corporation (GOCC) created under Republic Act No. 7227 (Bases Conversion and Development Act of 1992). BCDA is mandated to convert former US military bases and other Philippine military reservations into alternative productive civilian use — including economic zones, business parks, tourism estates, and infrastructure projects. BCDA’s major development projects include Clark Freeport Zone (former Clark Air Base), Subic Bay Freeport Zone (co-developed with SBMA), Bonifacio Global City (BGC) (former Fort Bonifacio), Clark International Airport expansion, and the Subic-Clark-Tarlac Expressway (SCTEX). BCDA is under the Office of the President of the Philippines. (Wikipedia — BCDA)

    Identities

    Source Type Identity
    Wikipedia Bases Conversion and Development Authority
    Wikidata N/A
    DBpedia N/A
    ProductOntology GovernmentAgency
    Wiktionary N/A
    LCSH Bases Conversion and Development Authority (Philippines)
    MeSH N/A
    NCBI Taxonomy N/A
    AGROVOC N/A
    Google Scholar BCDA Philippines Clark Subic BGC state-owned enterprise
    ConceptNet N/A
    OpenCyc N/A

    Also Known As

    • BCDA
    • Bases Conversion and Development Authority

    Usage Scenarios

    1. Clark Freeport Zone Development

    BCDA develops and administers Clark Freeport (former Clark Air Base) — a major economic zone hosting manufacturing, BPO, logistics, and aviation enterprises.

    2. Bonifacio Global City (BGC)

    BCDA pioneered the BGC master-planned development on former Fort Bonifacio military reservation land — now one of Metro Manila’s premier business districts.

    3. Infrastructure Development

    BCDA builds toll roads (SCTEX), airports (Clark International Airport expansion), and logistics infrastructure connecting its economic zones.

    4. AFP Modernization Funding

    BCDA remits a portion of its revenues to the Armed Forces of the Philippines (AFP) modernization program — a statutory requirement under RA 7227.

    Strategies

    • State-led master development of converted military lands
    • Public-Private Partnership (PPP) for project execution
    • Revenue remittance to AFP modernization

    Historical Context

    BCDA was created by RA 7227 signed by President Corazon C. Aquino in 1992, following the 1991 Philippine Senate rejection of the US Bases Treaty — triggering the withdrawal of US military forces from Clark, Subic, and other Philippine installations.

    Challenges and Controversies

    Governance and Audit Concerns

    BCDA has faced periodic governance and state-audit scrutiny over its large-scale development projects and PPP arrangements.

    Clark Development Pace

    Clark Freeport development has been slower than originally envisioned, though accelerating in the 2020s.

    AFP Modernization Funding Disputes

    Statutory revenue remittance to the AFP has been the subject of periodic legal and inter-agency disputes.

    Related Topic

    • Clark Freeport Zone
    • Clark International Airport
    • Subic Bay Freeport Zone
    • Bonifacio Global City (BGC)
    • Subic-Clark-Tarlac Expressway (SCTEX)
    • Republic Act No. 7227 (Bases Conversion and Development Act of 1992)
    • Department of National Defense (Philippines)
    • Armed Forces of the Philippines (AFP)
    • Department of Public Works and Highways (Philippines)

    References

    1. Wikipedia — Bases Conversion and Development Authority

  • Intramuros

    Definition

    Intramuros (Latin for “within the walls”) is the historic walled city of Manila, Philippines — a 0.67-square-kilometer district enclosed by stone walls constructed during the Spanish colonial period beginning in the late 16th century. Intramuros was the political, religious, and military center of the Spanish East Indies from its founding in 1571 by Spanish conquistador Miguel López de Legazpi until the end of Spanish rule in 1898. Today, Intramuros is administered by the Intramuros Administration (under the Department of Tourism) and is a major Philippine heritage-tourism destination containing landmark institutions including San Agustin Church (UNESCO World Heritage Site), Manila Cathedral, Fort Santiago, and reconstructed Spanish-colonial-era buildings. (Wikipedia — Intramuros)

    Identities

    Source Type Identity
    Wikipedia Intramuros
    Wikidata Intramuros (Q385842)
    DBpedia Intramuros
    ProductOntology Place
    Wiktionary N/A
    LCSH Intramuros (Manila, Philippines) / Historic sites — Philippines
    MeSH N/A
    NCBI Taxonomy N/A
    AGROVOC N/A
    Google Scholar Intramuros Manila Spanish colonial heritage Philippines
    ConceptNet N/A
    OpenCyc N/A

    Also Known As

    • Intramuros
    • Walled City of Manila
    • “The Walled City”

    Usage Scenarios

    1. Heritage Tourism

    Visitors explore Fort Santiago, San Agustin Church, Manila Cathedral, Baluarte de San Diego, and reconstructed colonial streetscapes.

    2. Cultural and Educational Programming

    Intramuros hosts museums, cultural performances, educational tours, and periodic heritage events.

    3. Institutional Seat

    Several Philippine educational institutions (Mapúa University, Colegio de San Juan de Letran, Lyceum of the Philippines University, Pamantasan ng Lungsod ng Maynila) are located within or adjacent to Intramuros.

    Strategies

    • Heritage conservation under Intramuros Administration (DOT)
    • Adaptive reuse of historic structures
    • Tourism development balancing preservation with access

    Historical Context

    Intramuros was established in 1571 by Miguel López de Legazpi as the capital of the new Spanish colony. The walls were constructed progressively from the late 1500s through the 1700s. Intramuros housed the highest levels of Spanish colonial government, the Catholic Church hierarchy, and the military garrison.

    Heavy damage during the 1945 Battle of Manila destroyed much of Intramuros. Post-war reconstruction and the establishment of the Intramuros Administration in 1979 initiated systematic heritage-restoration work that continues today.

    Challenges and Controversies

    Preservation vs Commercial Development

    Balancing heritage preservation with commercial-institutional pressure on Intramuros real estate.

    Traffic and Accessibility

    Intramuros sits within Metro Manila’s congested traffic corridor.

    Earthquake and Typhoon Vulnerability

    Historic structures require ongoing structural reinforcement.

    Related Topic

    • Manila
    • Miguel López de Legazpi
    • San Agustin Church (Manila)
    • Fort Santiago
    • Department of Tourism (Philippines)
    • Spanish colonial period in the Philippines
    • Battle of Manila (1945)
    • UNESCO World Heritage Sites in the Philippines

    References

    1. Wikipedia — Intramuros

  • Medical Tourism in the Philippines

    Definition

    Medical Tourism in the Philippines refers to the industry of foreign patients traveling to the Philippines for medical treatment, dental care, cosmetic/aesthetic procedures, and wellness services. The sector is promoted by the Department of Tourism (DOT) in coordination with the Department of Health (DOH) under the Philippine Medical Tourism Program. Key destination cities include Metro Manila, Cebu City, and Davao City. Major service categories include cosmetic/aesthetic surgery, dental procedures, ophthalmologic procedures (LASIK, cataract), cardiology, orthopedic surgery, and IVF/fertility treatments. The Philippines competes with Thailand, India, Singapore, Malaysia, and South Korea in the Asian medical-tourism market. (Wikipedia — Medical tourism in the Philippines)

    Identities

    Source Type Identity
    Wikipedia Medical tourism in the Philippines
    Wikidata N/A
    DBpedia N/A
    ProductOntology N/A
    Wiktionary N/A
    LCSH Medical tourism — Philippines
    MeSH N/A
    NCBI Taxonomy N/A
    AGROVOC N/A
    Google Scholar medical tourism Philippines DOT DOH cosmetic surgery
    ConceptNet N/A
    OpenCyc N/A

    Also Known As

    • Philippine medical tourism
    • Healthcare tourism Philippines

    Usage Scenarios

    1. Cosmetic and Aesthetic Surgery Tourism

    Foreign patients (Australian, American, Korean, Middle Eastern) travel to Manila and Cebu for lower-cost rhinoplasty, blepharoplasty, breast augmentation, and other aesthetic procedures.

    2. Dental Tourism

    Dental implants, crowns, and cosmetic dentistry at 30–60% lower cost than in Australia, US, or Europe.

    3. Wellness and IV Therapy

    Growing market for physician-supervised wellness programs — IV micronutrient therapy, metabolic health assessments, peptide therapy protocols.

    4. Specialty Medical Care

    Ophthalmologic surgery (LASIK, cataract), cardiac procedures, and orthopedic surgery at Joint Commission International (JCI)-accredited Philippine hospitals (St. Luke’s Medical Center, The Medical City).

    Strategies

    • English-language advantage — Philippine physicians and staff are English-proficient
    • Cost arbitrage — 30–70% lower procedure costs vs. US/Europe/Australia
    • JCI-accredited hospitals signal quality to international patients
    • DOT-DOH coordinated promotion via Philippine Medical Tourism Program

    Security and Safety Measures

    • Verify physician PRC licensure and specialty-board certification
    • Verify hospital JCI accreditation or DOH accreditation
    • FDA Philippines product registration for any prescribed pharmacotherapy
    • Medical-travel insurance covering post-procedure complications

    Historical Context

    The Philippine medical-tourism sector developed in the 2000s as a deliberate government economic-development strategy, with DOT and DOH jointly promoting Philippine healthcare services to international markets. The sector has grown but has not matched the scale of Thailand or India.

    Challenges and Controversies

    Competitive Position

    Philippines trails Thailand, India, Singapore, and Malaysia in medical-tourist arrivals — reflecting marketing investment, infrastructure, and regulatory-bottleneck gaps.

    Quality Standardization

    While JCI-accredited hospitals (St. Luke’s, The Medical City) meet international standards, smaller clinics serving medical tourists have variable quality.

    Complicated GLP-1 Access for Tourists

    Foreign visitors seeking GLP-1 weight-loss therapy encounter supply constraints and regulatory-eligibility requirements.

    Related Topic

    • Department of Tourism (Philippines)
    • Department of Health (Philippines)
    • St. Luke’s Medical Center
    • The Medical City
    • Aesthetic Medicine
    • Dermatology
    • Philippine Dermatological Society (PDS)
    • Philippine Association of Plastic, Reconstructive and Aesthetic Surgeons (PAPRAS)
    • Cebu City
    • Davao City

    References

    1. Wikipedia — Medical tourism (general reference)

  • Aesthetic Medicine

    Definition

    Aesthetic Medicine is a branch of clinical medicine focused on improving cosmetic appearance through non-surgical and minimally invasive procedures, including injectable treatments (botulinum toxin, dermal fillers), energy-based devices (lasers, intense pulsed light, radiofrequency, ultrasound), chemical peels, thread lifts, body-contouring technologies, and topical cosmeceutical protocols. In the Philippines, aesthetic medicine overlaps with dermatology (PDS-certified), plastic and reconstructive surgery (PAPRAS-certified), and a growing number of dedicated aesthetic clinics and medical spas. The field is regulated by the Food and Drug Administration (FDA) Philippines for product and device safety, and by the Professional Regulation Commission (PRC) for practitioner licensure. (Wikipedia — Aesthetic medicine)

    Identities

    Source Type Identity
    Wikipedia Aesthetic medicine
    Wikidata N/A
    DBpedia N/A
    ProductOntology N/A
    Wiktionary N/A
    LCSH Dermatologic surgery / Cosmetic surgery
    MeSH N/A
    NCBI Taxonomy N/A
    AGROVOC N/A
    Google Scholar aesthetic medicine Philippines cosmetic procedures clinics
    ConceptNet N/A
    OpenCyc N/A

    Also Known As

    • Cosmetic medicine
    • Medical aesthetics
    • Aesthetic dermatology

    Usage Scenarios

    1. Injectable Treatments

    Botulinum toxin (Botox, Xeomin), dermal fillers (hyaluronic acid, calcium hydroxylapatite), poly-L-lactic acid (Sculptra), and fat-dissolving injections (deoxycholic acid).

    2. Energy-Based Device Treatments

    Laser resurfacing (CO2, pico, fractional), IPL, radiofrequency skin tightening, ultrasound (HIFU), cryolipolysis (fat freezing).

    3. Chemical Peels and Topical Protocols

    Glycolic acid, salicylic acid, trichloroacetic acid peels; prescription-strength topical retinoids, hydroquinone, and combination protocols.

    4. Thread Lifts and Minimally Invasive Body Contouring

    PDO/PLA thread lifts, intragastric balloons, injection lipolysis.

    Strategies

    • Physician-supervised model — procedures performed by or under supervision of licensed physicians
    • Combination therapy — multi-modal protocols combining injectables + energy devices + topicals
    • Preventive aesthetic medicine — early intervention to delay visible aging

    Security and Safety Measures

    • Practitioner must be a PRC-licensed physician (ideally PDS-certified dermatologist or PAPRAS-certified plastic surgeon)
    • Products must be FDA Philippines CPN/CPR registered
    • Avoid counterfeit injectables sold through unauthorized channels
    • Proper facility standards: sterile environment, emergency protocols

    Historical Context

    Philippine aesthetic medicine grew rapidly in the 2000s–2020s, driven by increasing disposable income, social-media-driven beauty standards, and the proliferation of aesthetic clinics in Metro Manila, Cebu, and Davao. The field straddles dermatology, plastic surgery, and a regulatory gray zone where some procedures are performed by non-physician personnel in beauty salons — a recurring patient-safety concern.

    Challenges and Controversies

    Non-Physician Practice

    Beauty salons and aesthetic clinics offering injectable and laser procedures without physician supervision remain a regulatory enforcement challenge.

    Counterfeit Injectables

    Counterfeit Botox and dermal fillers sold through social media represent a significant patient-safety risk.

    Marketing Ethics

    “Botox” and “filler” promotional marketing on social media tests PMA Code of Ethics restrictions on physician advertising.

    Related Topic

    • Dermatology
    • Philippine Dermatological Society (PDS)
    • Philippine Association of Plastic, Reconstructive and Aesthetic Surgeons (PAPRAS)
    • Food and Drug Administration (FDA) Philippines
    • Cosmetics regulation in the Philippines
    • Medical Tourism in the Philippines
    • Botulinum toxin
    • Dermal fillers
    • Thread lift
    • Laser skin resurfacing

    References

    1. Wikipedia — Aesthetic medicine

  • Cosmetics Regulation in the Philippines

    Definition

    Cosmetics regulation in the Philippines is administered by the Food and Drug Administration (FDA) Philippines through its Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research (CCHUHSRR). The regulatory framework is established by Republic Act No. 9711 (FDA Act of 2009), Administrative Order No. 2016-0003 (adoption of the ASEAN Cosmetic Directive), and related FDA circulars. Philippine cosmetics regulation follows an ASEAN-harmonized notification model — cosmetic products require a Certificate of Product Notification (CPN) before market entry, rather than the full registration (CPR) required for drugs and devices. Cosmetic establishments (manufacturers, importers, distributors) require an FDA License to Operate (LTO). The regulatory framework distinguishes cosmetics (CPN, lower burden) from drugs (CPR, clinical data required) — a boundary frequently tested by products making therapeutic claims. (FDA Philippines, ASEAN Cosmetic Directive)

    Identities

    Source Type Identity
    Wikipedia Cosmetics regulation
    Wikidata N/A
    DBpedia N/A
    ProductOntology N/A
    Wiktionary N/A
    LCSH Cosmetics — Law and legislation — Philippines
    MeSH N/A
    NCBI Taxonomy N/A
    AGROVOC N/A
    Google Scholar cosmetics regulation Philippines FDA CPN ASEAN
    ConceptNet N/A
    OpenCyc N/A

    Also Known As

    • Philippine cosmetic regulatory framework
    • FDA cosmetics notification
    • ASEAN Cosmetic Directive (Philippine adoption)

    Usage Scenarios

    1. Certificate of Product Notification (CPN)

    Cosmetic manufacturers and importers submit product formulation + labeling documentation to the FDA CCHUHSRR. Upon review, the FDA issues a CPN — allowing legal market entry. CPN does not equal “FDA approval” — it is a notification framework, not a pre-market efficacy review.

    2. License to Operate (LTO)

    Cosmetic manufacturing, importation, and distribution establishments must hold a current FDA LTO separate from per-product CPNs.

    3. Cosmetic vs Drug Claim Boundary

    Products marketed with therapeutic claims (e.g., “treats melasma,” “cures acne”) cross from cosmetic (CPN) to drug (CPR with clinical data) regulatory category — a recurring Philippine enforcement issue for skincare brands.

    4. ASEAN Cosmetic Directive Harmonization

    The Philippines adopted the ASEAN Cosmetic Directive via AO 2016-0003, harmonizing ingredient restrictions, labeling requirements, and notification procedures with ASEAN partners (Indonesia, Malaysia, Thailand, Singapore, etc.).

    Strategies

    • Notification-based model (CPN) rather than full pre-market approval — faster market entry but lower pre-market scrutiny
    • ASEAN harmonization — regional consistency for cross-border cosmetic trade
    • Post-market surveillance — FDA monitors adverse events and conducts enforcement against unregistered products

    Security and Safety Measures

    • CPN requirement for all cosmetics sold in the Philippines
    • LTO requirement for cosmetic establishments
    • Prohibited/restricted ingredient lists per ASEAN Cosmetic Directive
    • Labeling requirements: ingredient list, batch number, expiration date, country of manufacture, net weight
    • Post-market adverse-event reporting

    Historical Context

    Philippine cosmetics regulation evolved from the BFAD era (under RA 3720, 1963) through the FDA era (under RA 9711, 2009). The adoption of the ASEAN Cosmetic Directive via AO 2016-0003 represented a major modernization — aligning Philippine cosmetics regulation with regional ASEAN practice and replacing the older pre-market registration model with a notification-based framework.

    Challenges and Controversies

    Cosmetic vs Drug Claim Enforcement

    The boundary between permissible cosmetic claims (“brightening”) and impermissible drug claims (“treats hyperpigmentation”) is a recurring enforcement issue.

    Compounded Cosmetics

    Compounded skincare products (custom hydroquinone, tretinoin formulations) bypass CPN requirements — a regulatory gap.

    Counterfeit and Unregistered Products

    Social-media-sold counterfeit and unregistered cosmetics remain a significant enforcement challenge.

    Verification Portal Limitations

    The FDA’s verification portal (verification.fda.gov.ph) is JavaScript-only, complicating batch verification.

    Related Topic

    • Food and Drug Administration (FDA) Philippines
    • Republic Act No. 9711 (FDA Act of 2009)
    • ASEAN Cosmetic Directive
    • Philippine Dermatological Society (PDS)
    • Cosmetics industry in the Philippines
    • Bioskin Tech Laboratories
    • Counterfeit pharmaceutical regulation

    References

    1. Food and Drug Administration of the Philippines — Official Portal
    2. Association of Southeast Asian Nations (ASEAN) — reference for ASEAN Cosmetic Directive

  • Obesity in the Philippines

    Definition

    Obesity in the Philippines is a growing public-health concern characterized by increasing prevalence of overweight and obesity across the Philippine population, driven by urbanization, dietary transition from traditional to processed foods, sedentary lifestyles (particularly in BPO and office-based employment), and limited access to preventive-medicine infrastructure. The Food and Nutrition Research Institute (FNRI) of the Department of Science and Technology conducts the National Nutrition Survey documenting prevalence trends. Filipino populations have a genetic predisposition to insulin resistance and metabolic syndrome at lower BMI thresholds than Western populations, making WHO Western Pacific Region BMI cut-offs (overweight ≥ 23 kg/m², obesity ≥ 25 kg/m²) more appropriate than international cut-offs (≥ 25 and ≥ 30 respectively). (FNRI-DOST National Nutrition Survey)

    Identities

    Source Type Identity
    Wikipedia Obesity in the Philippines
    Wikidata N/A
    DBpedia N/A
    ProductOntology N/A
    Wiktionary N/A
    LCSH Obesity — Philippines / Public health — Philippines
    MeSH Obesity
    NCBI Taxonomy N/A
    AGROVOC N/A
    Google Scholar obesity prevalence Philippines FNRI nutrition survey
    ConceptNet N/A
    OpenCyc N/A

    Also Known As

    • Obesity epidemic Philippines
    • Filipino obesity

    Examples and Analogies

    • Asian-specific BMI concern: Filipinos develop Type 2 diabetes and cardiovascular disease at lower BMI than Caucasians. A Filipino with BMI 24 (classified “normal” by WHO international standards) may already have metabolic syndrome requiring intervention under WHO Western Pacific cut-offs.

    Usage Scenarios

    1. Clinical Weight Management

    Physicians screen for obesity using Asian-specific BMI cut-offs, waist circumference, and metabolic-panel biomarkers. GLP-1 receptor agonist therapy may be prescribed where clinically indicated.

    2. Public Health Policy

    DOH and FNRI develop population-level interventions — sugar-sweetened beverage taxes (TRAIN Law), school nutrition programs, workplace wellness campaigns.

    3. BPO Sector Metabolic Health

    Sedentary BPO-sector employees represent a high-risk demographic — shift work, irregular eating, limited physical activity.

    Strategies

    • Use Asian-specific BMI cut-offs (overweight ≥ 23, obesity ≥ 25)
    • Combine pharmacotherapy (GLP-1 RAs where indicated) with structured lifestyle modification
    • Address Filipino diet patterns (high white-rice consumption, sweetened beverages)

    Security and Safety Measures

    • Screen for comorbidities: Type 2 diabetes, hypertension, dyslipidemia, MASLD
    • Avoid unregulated weight-loss products sold through social media
    • Physician supervision for any pharmacological weight-management program

    Historical Context

    The Philippines has historically had low obesity rates compared to Western countries, but prevalence has risen sharply since the 2000s — mirroring broader Southeast Asian trends. The FNRI National Nutrition Survey documents this trajectory across survey rounds. The TRAIN Law (RA 10963, 2018) imposed a sugar-sweetened beverage tax partly motivated by obesity-prevention objectives.

    Challenges and Controversies

    BMI Threshold Calibration

    Western BMI cut-offs under-detect Filipino metabolic risk. WHO Western Pacific cut-offs (lower thresholds) are not consistently applied in Philippine clinical practice.

    Access to Advanced Therapeutics

    GLP-1 receptor agonists and other advanced obesity pharmacotherapy are PhilHealth-excluded and premium-priced, creating access disparities.

    Cultural Acceptance of Higher Body Weight

    Filipino cultural norms may be more accepting of higher body weight than clinical guidelines recommend, complicating patient-physician communication.

    Related Topic

    • GLP-1 Receptor Agonists
    • Insulin Resistance
    • Type 2 Diabetes Mellitus
    • Philippine Society of Endocrinology, Diabetes and Metabolism (PSEDM)
    • Philippine College of Physicians (PCP)
    • Food and Nutrition Research Institute (FNRI)
    • Department of Health (Philippines)
    • TRAIN Law (RA 10963)
    • Body Mass Index

    References

    1. Wikipedia — Obesity in the Philippines

  • Philippine Society of Endocrinology, Diabetes and Metabolism

    Definition

    The Philippine Society of Endocrinology, Diabetes and Metabolism (PSEDM) is the national professional specialty society of endocrinologists (specialists in endocrine disorders, diabetes, and metabolic diseases) in the Philippines. The PSEDM is the authoritative body for endocrinology specialty training accreditation, board certification (diplomate status), clinical practice guidelines, and continuing medical education in the Philippine setting. The Society works in coordination with the Philippine College of Physicians (PCP) as a recognized subspecialty component, and with the Food and Drug Administration (FDA) Philippines and the Department of Health (DOH) on diabetes and metabolic-disease public health policy. (Wikipedia — PSEDM)

    Identities

    Source Type Identity
    Wikipedia Philippine Society of Endocrinology, Diabetes and Metabolism
    Wikidata N/A
    DBpedia N/A
    ProductOntology N/A
    Wiktionary N/A
    Library of Congress Subject Headings (LCSH) Endocrinology — Philippines / Diabetes — Philippines
    MeSH N/A
    NCBI Taxonomy N/A
    AGROVOC N/A
    Google Scholar “PSEDM” Philippines endocrinology diabetes guidelines
    ConceptNet N/A
    OpenCyc N/A

    Also Known As

    • PSEDM
    • Philippine Society of Endocrinology
    • PSEDM-Endocrine Society

    Examples and Analogies

    • National specialty-society analog: PSEDM is structurally analogous to the American Association of Clinical Endocrinologists (AACE) and the Endocrine Society (US) — a national specialty society of endocrinologists.

    Usage Scenarios

    1. Endocrinology Specialty Training Accreditation

    PSEDM accredits endocrinology fellowship (subspecialty) training programs in Philippine teaching hospitals.

    2. Clinical Practice Guidelines

    PSEDM develops Philippine CPGs for Type 2 diabetes, thyroid disorders, osteoporosis, dyslipidemia, obesity management, and other endocrine-metabolic conditions.

    3. GLP-1 Therapy Guidance

    PSEDM has issued clinical guidance on GLP-1 receptor agonist prescribing in the Philippines — including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda, Victoza).

    4. Public Health Advocacy

    Advocates for diabetes prevention, metabolic syndrome awareness, and rational pharmacotherapy — in coordination with DOH, PhilHealth, and PCP.

    Strategies

    • Specialty training and diplomate certification authority
    • Clinical practice guideline development
    • Coordination with PCP, DOH, FDA Philippines, and PhilHealth
    • Public education on diabetes and metabolic disease

    Security and Safety Measures

    • Diplomate certification ensures endocrinologist credentialing
    • CPGs inform safe clinical practice
    • Coordination with FDA on pharmacotherapy safety advisories

    Historical Context

    The PSEDM was established to consolidate Philippine endocrinology as a recognized subspecialty within Internal Medicine. The Society has been instrumental in developing Philippine diabetes management standards, including the adoption and dissemination of incretin-based therapy (GLP-1 receptor agonists, DPP-4 inhibitors) in Philippine clinical practice.

    Challenges and Controversies

    Workforce Distribution

    Endocrinologists are concentrated in Metro Manila and major regional centers, limiting access in provincial areas.

    GLP-1 Compounding Warnings

    PSEDM has joined the FDA Philippines and PCP in issuing public warnings against compounded GLP-1 products.

    PhilHealth Coverage Gaps

    Advanced endocrine pharmacotherapy (GLP-1 receptor agonists, SGLT2 inhibitors) is largely not covered by PhilHealth, creating access disparities.

    Related Topic

    • Philippine College of Physicians (PCP)
    • Department of Health (Philippines)
    • Food and Drug Administration (FDA) Philippines
    • PhilHealth
    • Type 2 Diabetes Mellitus
    • Insulin Resistance
    • GLP-1 Receptor Agonists
    • Semaglutide
    • Tirzepatide
    • Liraglutide
    • Metabolic syndrome

    References

    1. Wikipedia — Endocrinology (general reference)

  • Dalil Salam Solutions Inc.

    Definition

    Dalil Salam Solutions Inc. is a privately held Philippine B2B consultancy firm based in Davao City, Philippines. Per its live corporate website (dalilsalam.com.ph), the company positions itself as a specialist in corporate setup, SEC registration, paralegal research, trading and distribution consulting, and corporate administration — serving Philippine trading and distribution sector enterprises. The company was founded by Hajji Jeffrey Andante Prevendido (see separate entry), who also serves as its CEO. Dalil Salam is additionally positioned within the unpublished marketing materials for the Purpose Beyond Profits movement — a values-based leadership ecosystem involving multiple ventures and speakers including author Art Bonjoc Jr. (Dalil Salam Solutions Inc. — official portal)

    Identities

    Source Type Identity
    Wikipedia N/A
    Wikidata N/A
    DBpedia N/A
    ProductOntology Corporation
    Wiktionary N/A
    Library of Congress Subject Headings (LCSH) Business enterprises — Philippines / Consulting firms — Philippines
    MeSH N/A
    NCBI Taxonomy N/A
    AGROVOC N/A
    Google Scholar “Dalil Salam Solutions” Philippines Davao
    ConceptNet N/A
    OpenCyc N/A

    Also Known As

    • Dalil Salam
    • Dalil Salam Solutions
    • DSSI

    Examples and Analogies

    • Consultancy-firm analog: Dalil Salam is structurally analogous to small-to-mid-tier Philippine B2B consultancies that handle corporate registration, compliance advisory, and operational consulting for trading and distribution companies.

    Usage Scenarios

    1. Corporate Setup and SEC Registration

    End-to-end SEC incorporation, business permits, corporate structuring advisory, and post-incorporation compliance.

    2. Paralegal Research and Compliance

    Regulatory framework analysis, contract review preparation, due diligence support, and policy drafting.

    3. Trading and Distribution Consulting

    Supply chain optimization, distribution network structuring, vendor management advisory.

    4. Purpose Beyond Profits Movement Ecosystem

    Unpublished marketing materials position Dalil Salam within the broader Purpose Beyond Profits ecosystem alongside the Balik Islam Council and author Art Bonjoc Jr.’s keynote speaking work.

    Strategies

    • Specialized B2B positioning (corporate setup + paralegal + distribution)
    • Davao City geographic base
    • Cross-venture ecosystem with founder’s other entities

    Security and Safety Measures

    • SEC corporate-registration compliance
    • BIR tax-registration compliance
    • Standard Philippine corporate governance

    Historical Context

    Dalil Salam Solutions Inc. was founded by Jeffrey Andante Prevendido. The company’s live corporate website positions it as a B2B consultancy; unpublished marketing materials for the Purpose Beyond Profits movement suggest a broader venture-builder and faith-aligned enterprise vision that is not yet fully reflected on the live site.

    Challenges and Controversies

    Founder’s Dismissed SSS Case

    Founder Jeffrey Andante Prevendido was the employer in a dismissed R.A. 11199 (Social Security Act) criminal case — see Jeffrey Andante Prevendido entry for full documentation. The case was dismissed per RTC Branch 54 Clearance (July 24, 2026).

    Purpose Beyond Profits Ecosystem Pre-Launch Status

    The Purpose Beyond Profits brand ecosystem (book, movement, multi-speaker platform) is not yet reflected on the live Dalil Salam corporate website as of July 2026.

    Related Topic

    • Jeffrey Andante Prevendido
    • Art Bonjoc Jr.
    • Purpose Beyond Profits (book)
    • Balik Islam Council of the Philippines Inc.
    • SEC Philippines
    • Department of Trade and Industry (DTI) Philippines
    • Davao City

    References

    1. Dalil Salam Solutions Inc. — Official Portal

  • Department of Trade and Industry (Philippines)

    Definition

    The Department of Trade and Industry (DTI) is the executive department of the Government of the Philippines responsible for trade, industry, and investment promotion. The DTI is the principal national-government agency tasked with fostering a competitive and innovative Philippine business environment, protecting consumer rights, and promoting Philippine exports and MSME development. Led by the Secretary of Trade and Industry (Cabinet rank), the DTI exercises administrative supervision over the Board of Investments (BOI), the Securities and Exchange Commission (SEC), the Small Business Corporation (SB Corp), the Philippine Trade Training Center (PTTC), the Bureau of Import Services (BIS), the Bureau of Domestic Trade (BDT), and the Consumer Protection Bureau. The DTI operates Negosyo Centers across the Philippines under the Go Negosyo Act (RA 10644). (Wikipedia — Department of Trade and Industry)

    Identities

    Source Type Identity
    Wikipedia Department of Trade and Industry (Philippines)
    Wikidata Department of Trade and Industry (Q5258650)
    DBpedia N/A
    ProductOntology GovernmentAgency
    Wiktionary N/A
    Library of Congress Subject Headings (LCSH) Trade — Philippines / Industry — Philippines
    MeSH N/A
    NCBI Taxonomy N/A
    AGROVOC N/A
    Google Scholar “DTI Philippines” trade policy MSME
    ConceptNet N/A
    OpenCyc N/A

    Also Known As

    • DTI
    • Department of Trade and Industry
    • Kagawaran ng Kalakalan at Industriya (Filipino)

    Examples and Analogies

    • National analog: DTI is structurally analogous to the US Department of Commerce, the UK Department for Business and Trade, and similar national trade-and-industry ministries globally.

    Usage Scenarios

    1. MSME Development

    Through SB Corp, BMSMED, and the Negosyo Center network — supports Micro, Small, and Medium Enterprises with registration, financing, capacity-building, and market access.

    2. Consumer Protection

    Enforces the Consumer Act of the Philippines (RA 7394) — product standards, price tags, warranties, complaints resolution.

    3. Investment Promotion

    Through BOI — administers the Omnibus Investments Code (EO 226) and the CREATE Act (RA 11534) tax incentives for registered enterprises.

    4. Export Development

    Through the Export Marketing Councils and Philippine Trade Training Centers — supports Philippine exporters with trade fairs (Manila FAME, IFEX), market intelligence, and capacity-building.

    5. Trade Policy and International Negotiations

    DTI participates in ASEAN, WTO, and bilateral trade agreement negotiations.

    Strategies

    • Cabinet-rank Secretary with direct line to the President
    • Attached-agency model (BOI, SEC, SB Corp, PTTC)
    • Negosyo Center physical network across the Philippines (RA 10644)
    • Consumer protection enforcement under RA 7394

    Security and Safety Measures

    • Consumer Act (RA 7394) enforcement: product safety standards, labeling, price regulation
    • Price freeze authority during disasters and emergencies
    • Import monitoring and anti-dumping

    Historical Context

    The DTI was formally established by Executive Order No. 133 (January 30, 1987) as part of the post-EDSA government reorganization under President Corazon C. Aquino, separating trade-and-industry functions from the former Ministry of Trade and Industry.

    Key legislative milestones:
    – 1991: Consumer Act (RA 7394)
    – 2008: Magna Carta for MSMEs (RA 9501)
    – 2014: Go Negosyo Act (RA 10644) — Negosyo Centers
    – 2021: CREATE Act (RA 11534) — corporate tax reform

    Challenges and Controversies

    MSME Financing Access

    Despite Magna Carta mandates, MSME financing remains constrained.

    Consumer Protection Enforcement Scale

    DTI consumer-protection reach is limited relative to the scale of the Philippine retail market and the proliferation of online marketplaces.

    Trade Policy Balance

    Balancing free-trade commitments (ASEAN, WTO) with domestic-industry protection is a recurring policy tension.

    Related Topic

    • Board of Investments (BOI)
    • Securities and Exchange Commission (SEC)
    • Small Business Corporation (SB Corp)
    • Consumer Act of the Philippines (RA 7394)
    • Magna Carta for MSMEs (RA 9501)
    • Go Negosyo Act (RA 10644)
    • CREATE Act (RA 11534)
    • Micro, Small and Medium Enterprises (MSMEs) in the Philippines
    • Negosyo Centers
    • Sta. Cruz Chamber of Commerce and Industry Inc.

    References

    1. Wikipedia — Department of Trade and Industry (Philippines)

  • ABS-CBN Broadcasting Corporation

    Definition

    ABS-CBN Broadcasting Corporation (later ABS-CBN Corporation, PSE: ABS) was the Philippines’ largest media and entertainment conglomerate prior to the May 2020 non-renewal of its congressional franchise. Founded in 1946 by Judge Eugenio Lopez Sr. and Fernando Lopez, ABS-CBN operated the country’s dominant television network, radio stations, film production (Star Cinema), music label (Star Music), and digital platforms until the National Telecommunications Commission (NTC) issued a cease-and-desist order on May 5, 2020, following the expiry of its 25-year legislative franchise. The House Committee on Legislative Franchises subsequently voted on July 10, 2020 to deny the franchise renewal application — resulting in the closure of broadcast operations, mass layoffs, and the company’s pivot to digital and international content distribution. (Wikipedia — ABS-CBN)

    Identities

    Source Type Identity
    Wikipedia ABS-CBN
    Wikidata ABS-CBN (Q59566)
    DBpedia ABS-CBN
    ProductOntology Organization / Corporation
    Wiktionary N/A
    Library of Congress Subject Headings (LCSH) Television broadcasting — Philippines
    MeSH N/A
    NCBI Taxonomy N/A
    AGROVOC N/A
    Google Scholar “ABS-CBN” franchise Philippines broadcast media
    ConceptNet N/A
    OpenCyc N/A

    Also Known As

    • ABS-CBN
    • ABS-CBN Corporation
    • “The Kapamilya Network” (brand identity)
    • Alto Broadcasting System – Chronicle Broadcasting Network (historical)

    Examples and Analogies

    • National media conglomerate analog: ABS-CBN’s pre-2020 structure was analogous to major national broadcast-media conglomerates globally — combining free-to-air TV, cable/satellite channels, radio, film production, music, publishing, and digital platforms under one corporate umbrella.

    Usage Scenarios

    1. National Broadcast Television (1946–2020)

    Operated the Philippines’ most-watched TV network, including flagship news (TV Patrol, Bandila), entertainment programming, and sports coverage.

    2. Regional Broadcast Network

    The Regional Network Group (RNG) produced regional-language news and programming across the Visayas and Mindanao — including Northern Mindanao operations where Art Bonjoc Jr. served.

    3. Digital and International Pivot (Post-2020)

    Following the franchise denial, ABS-CBN pivoted to iWantTFC streaming, Kapamilya Channel (cable), A2Z (broadcast partnership with Zoe Broadcasting), and international content licensing.

    Strategies

    • Multi-platform media conglomerate model (TV + radio + film + music + digital)
    • Star system talent development (contract artists across acting, singing, hosting)
    • Regional network for national-regional audience coverage

    Security and Safety Measures

    • Operated under KBP Broadcast Code self-regulation
    • Subject to NTC technical regulation and congressional franchise requirements
    • Press freedom advocacy during and after the 2020 franchise fight

    Historical Context

    ABS-CBN traces its origins to Alto Broadcasting System (ABS), founded in 1946, which merged with Chronicle Broadcasting Network (CBN) in 1957 under the Lopez family. The network grew into the Philippines’ dominant broadcaster through the 1960s–2010s.

    The network was shut down during martial law (1972–1986) and reopened after the EDSA revolution. Its modern era (1987–2020) saw ABS-CBN become the Philippines’ most profitable and influential media company.

    On May 5, 2020, the NTC issued a cease-and-desist order after the network’s 25-year franchise expired. On July 10, 2020, the House Committee denied the franchise renewal — widely interpreted as politically motivated retaliation for critical coverage of the Duterte administration.

    Challenges and Controversies

    2020 Franchise Non-Renewal

    The most consequential event in modern Philippine media history — 7,000+ employees laid off, regional newsrooms closed, press-freedom implications domestically and internationally.

    Political Pressure

    The franchise denial followed years of tension between ABS-CBN and the Duterte administration over coverage.

    Post-2020 Business Model Viability

    ABS-CBN’s post-2020 digital-first model is profitable but operates at a fraction of its pre-2020 scale and cultural influence.

    Related Topic

    • ABS-CBN News and Current Affairs
    • TV Patrol
    • Art Bonjoc Jr.
    • Kapisanan ng mga Brodkaster ng Pilipinas (KBP)
    • National Telecommunications Commission (NTC)
    • GMA Network
    • TV5 Network
    • Boto Mo, Ipatrol Mo: Ako Ang Simula!

    References

    1. Wikipedia — ABS-CBN